Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia

The role of histone deacetylase inhibitors in the treatment of acute myeloid leukemia (AML) is not well characterized. The current study evaluated the safety and efficacy of panobinostat in combination with idarubicin and cytarabine in newly diagnosed patients aged ≤65 years with primary or secondar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DeAngelo, Daniel J. (VerfasserIn) , Walker, Alison R. (VerfasserIn) , Schlenk, Richard Friedrich (VerfasserIn) , Sierra, Jorge (VerfasserIn) , Medeiros, Bruno C. (VerfasserIn) , Ocio, Enrique M. (VerfasserIn) , Röllig, Christoph (VerfasserIn) , Strickland, Stephen A. (VerfasserIn) , Thol, Felicitas (VerfasserIn) , Valera, Sue-zette (VerfasserIn) , Dasgupta, Kohinoor (VerfasserIn) , Berkowitz, Noah (VerfasserIn) , Stuart, Robert K. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 01 August 2019
In: Leukemia research
Year: 2019, Jahrgang: 85
ISSN:1873-5835
DOI:10.1016/j.leukres.2019.106197
Online-Zugang:Verlag, Volltext: https://doi.org/10.1016/j.leukres.2019.106197
Verlag: http://www.sciencedirect.com/science/article/pii/S0145212619301420
Volltext
Verfasserangaben:Daniel J. DeAngelo, Alison R. Walker, Richard F. Schlenk, Jorge Sierra, Bruno C. Medeiros, Enrique M. Ocio, Christoph Röllig, Stephen A. Strickland, Felicitas Thol, Sue-zette Valera, Kohinoor Dasgupta, Noah Berkowitz, Robert K. Stuart

MARC

LEADER 00000caa a2200000 c 4500
001 1689862262
003 DE-627
005 20220817230053.0
007 cr uuu---uuuuu
008 200212s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.leukres.2019.106197  |2 doi 
035 |a (DE-627)1689862262 
035 |a (DE-599)KXP1689862262 
035 |a (OCoLC)1341305087 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a DeAngelo, Daniel J.  |e VerfasserIn  |0 (DE-588)1018240942  |0 (DE-627)68774413X  |0 (DE-576)359502342  |4 aut 
245 1 0 |a Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia  |c Daniel J. DeAngelo, Alison R. Walker, Richard F. Schlenk, Jorge Sierra, Bruno C. Medeiros, Enrique M. Ocio, Christoph Röllig, Stephen A. Strickland, Felicitas Thol, Sue-zette Valera, Kohinoor Dasgupta, Noah Berkowitz, Robert K. Stuart 
264 1 |c 01 August 2019 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 12.02.2020 
520 |a The role of histone deacetylase inhibitors in the treatment of acute myeloid leukemia (AML) is not well characterized. The current study evaluated the safety and efficacy of panobinostat in combination with idarubicin and cytarabine in newly diagnosed patients aged ≤65 years with primary or secondary high-risk AML based on cytogenetic classification. Treatment included fixed dose idarubicin (12mg/m2/d, IV; day 1–3) and cytarabine (100mg/m2/d, continuous IV infusion; day 1–7) and escalating oral doses of panobinostat at 15mg, 20mg, and 25mg, thrice weekly starting at week 2 of a 28-day cycle. Forty-six patients were enrolled (primary AML [n=36], secondary AML [n=10]). The median age was 55 years. The most common all-grade AEs were diarrhea (54.3%), nausea (39.1%), vomiting, and decreased appetite (each, 21.7%), stomatitis (19.6%), and fatigue (17.4%). The overall response rate was 60.9%, 43.5% achieved a complete remission (CR), and 17.4% achieved CR with incomplete count recovery. The event-free survival at 1-year was 78.3%. Panobinostat in combination with idarubicin and cytarabine demonstrated tolerable safety and efficacy in younger patients with high-risk AML. The recommended phase 2 dose of panobinostat in this combination was 20mg. ClinicalTrials.gov registry no: NCT01242774, and European Trial Registry EudraCT no: 2009-016809-42. 
650 4 |a Acute myeloid leukemia 
650 4 |a AML 
650 4 |a Cytarabine 
650 4 |a Idarubicin 
650 4 |a Panobinostat 
700 1 |a Walker, Alison R.  |e VerfasserIn  |4 aut 
700 1 |a Schlenk, Richard Friedrich  |d 1965-  |e VerfasserIn  |0 (DE-588)129025380  |0 (DE-627)387778004  |0 (DE-576)297454102  |4 aut 
700 1 |a Sierra, Jorge  |e VerfasserIn  |4 aut 
700 1 |a Medeiros, Bruno C.  |e VerfasserIn  |4 aut 
700 1 |a Ocio, Enrique M.  |e VerfasserIn  |4 aut 
700 1 |a Röllig, Christoph  |d 1971-  |e VerfasserIn  |0 (DE-588)122493168  |0 (DE-627)705929116  |0 (DE-576)293296049  |4 aut 
700 1 |a Strickland, Stephen A.  |e VerfasserIn  |4 aut 
700 1 |a Thol, Felicitas  |d 1977-  |e VerfasserIn  |0 (DE-588)129633984  |0 (DE-627)475217403  |0 (DE-576)297759329  |4 aut 
700 1 |a Valera, Sue-zette  |e VerfasserIn  |4 aut 
700 1 |a Dasgupta, Kohinoor  |e VerfasserIn  |4 aut 
700 1 |a Berkowitz, Noah  |e VerfasserIn  |4 aut 
700 1 |a Stuart, Robert K.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia research  |d Amsterdam [u.a.] : Elsevier Science, 1977  |g 85(2019) Artikel-Nummer 106197, 7 Seiten  |h Online-Ressource  |w (DE-627)320467031  |w (DE-600)2008028-1  |w (DE-576)095956301  |x 1873-5835  |7 nnas  |a Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia 
773 1 8 |g volume:85  |g year:2019  |g extent:7  |a Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia 
856 4 0 |u https://doi.org/10.1016/j.leukres.2019.106197  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0145212619301420  |x Verlag 
951 |a AR 
992 |a 20200212 
993 |a Article 
994 |a 2019 
998 |g 129025380  |a Schlenk, Richard Friedrich  |m 129025380:Schlenk, Richard Friedrich  |d 910000  |d 910100  |e 910000PS129025380  |e 910100PS129025380  |k 0/910000/  |k 1/910000/910100/  |p 3 
999 |a KXP-PPN1689862262  |e 3593776103 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia","title_sort":"Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1689862262"],"doi":["10.1016/j.leukres.2019.106197"]},"physDesc":[{"extent":"7 S."}],"relHost":[{"disp":"Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemiaLeukemia research","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1977 -"],"note":["Gesehen am 16.01.20","Ungezählte Beil.: Supplement"],"language":["eng"],"part":{"year":"2019","volume":"85","extent":"7","text":"85(2019) Artikel-Nummer 106197, 7 Seiten"},"origin":[{"publisher":"Elsevier Science","dateIssuedDisp":"1977-","dateIssuedKey":"1977","publisherPlace":"Amsterdam [u.a.]"}],"title":[{"title_sort":"Leukemia research","title":"Leukemia research","subtitle":"clinical and laboratory studies"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2008028-1"],"eki":["320467031"],"issn":["1873-5835"]},"recId":"320467031"}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"01 August 2019"}],"name":{"displayForm":["Daniel J. DeAngelo, Alison R. Walker, Richard F. Schlenk, Jorge Sierra, Bruno C. Medeiros, Enrique M. Ocio, Christoph Röllig, Stephen A. Strickland, Felicitas Thol, Sue-zette Valera, Kohinoor Dasgupta, Noah Berkowitz, Robert K. Stuart"]},"language":["eng"],"person":[{"given":"Daniel J.","display":"DeAngelo, Daniel J.","role":"aut","family":"DeAngelo"},{"display":"Walker, Alison R.","given":"Alison R.","family":"Walker","role":"aut"},{"display":"Schlenk, Richard Friedrich","given":"Richard Friedrich","family":"Schlenk","role":"aut"},{"given":"Jorge","display":"Sierra, Jorge","family":"Sierra","role":"aut"},{"role":"aut","family":"Medeiros","given":"Bruno C.","display":"Medeiros, Bruno C."},{"family":"Ocio","role":"aut","display":"Ocio, Enrique M.","given":"Enrique M."},{"family":"Röllig","role":"aut","display":"Röllig, Christoph","given":"Christoph"},{"given":"Stephen A.","display":"Strickland, Stephen A.","family":"Strickland","role":"aut"},{"family":"Thol","role":"aut","given":"Felicitas","display":"Thol, Felicitas"},{"role":"aut","family":"Valera","given":"Sue-zette","display":"Valera, Sue-zette"},{"family":"Dasgupta","role":"aut","display":"Dasgupta, Kohinoor","given":"Kohinoor"},{"given":"Noah","display":"Berkowitz, Noah","role":"aut","family":"Berkowitz"},{"given":"Robert K.","display":"Stuart, Robert K.","family":"Stuart","role":"aut"}],"recId":"1689862262","note":["Gesehen am 12.02.2020"]} 
SRT |a DEANGELODASAFETYANDE0120